Aeterna Zentaris to Present at BIO CEO Investor and RBC Capital Markets Global Healthcare Conferences in New York

QUÉBEC CITY, Feb. 7, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that Paul Blake, MD, the Company's Senior Vice President and Chief of Medical Affairs, will be presenting a Company overview at the BIO CEO Investor Conference on Tuesday, February 14, 2012, at 3:30 pm (Eastern), in the Duke of Windsor Room of the Waldorf Astoria Hotel in New York City.

Dr. Blake will also take part in a cancer panel during the RBC Capital Markets Global Healthcare Conference on Tuesday, February 28, 2012 at 11:00 am (Eastern) in the Holmes Room 1 of the New York Palace Hotel in New York City.

Live audio webcasts of these presentations will be available on Aeterna Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcasts will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, prostate and bladder cancer. The Company's innovative approach of "personalized medicine" means tailoring treatments to a patient's specific condition and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn from its proprietary discovery unit providing the Company with constant and long-term access to state-of-the-art therapeutic options. For more information please visit www.aezsinc.com.

For further information:

Investor Relations
Ginette Beaudet Vallières
Investor Relations Coordinator
[phone] ext. 265
[e-mail]

Chad Rubin
Vice President
The Trout Group LLC
[phone]
[e-mail]

Media Relations
Paul Burroughs
Director of Communications
[phone] ext. 406
[e-mail]